trientine has been researched along with carboplatin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, G; Guo, L; Liu, J; Wang, Y; Yin, F; Zheng, X | 1 |
| Fu, C; Fu, S; Kuo, MT; Kurzrock, R; Naing, A | 1 |
| Falchook, G; Fu, S; Hong, D; Hou, MM; Janku, F; Kuo, MT; Kurzrock, R; Naing, A; Piha-Paul, S; Tsimberidou, A; Wheler, J; Zinner, R | 1 |
2 trial(s) available for trientine and carboplatin
| Article | Year |
|---|---|
Overcoming platinum resistance through the use of a copper-lowering agent.
Topics: Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Ovarian Epithelial; Cation Transport Proteins; Chelating Agents; Copper; Copper Transporter 1; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Humans; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Pilot Projects; Trientine | 2012 |
Exploratory study of carboplatin plus the copper-lowering agent trientine in patients with advanced malignancies.
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Ceruloplasmin; Chelating Agents; Copper; Female; Humans; Male; Middle Aged; Neoplasms; Treatment Outcome; Trientine | 2014 |
1 other study(ies) available for trientine and carboplatin
| Article | Year |
|---|---|
Characterization and antitumor activity of triethylene tetramine, a novel telomerase inhibitor.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Blotting, Western; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cyclophosphamide; Doxorubicin; Female; HeLa Cells; Humans; Indicators and Reagents; Mice; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; Sarcoma 180; Telomerase; Tetrazolium Salts; Thiazoles; Trientine | 2008 |